Rhinosinusitis: Developing guidance for clinical trials

Eli O. Meltzer, Daniel L. Hamilos, James A. Hadley, Donald C. Lanza, Bradley F. Marple, Richard A. Nicklas, Allen D. Adinoff, Claus Bachert, Larry Borish, Vernon M. Chinchilli, Melvyn R. Danzig, Berrylin J. Ferguson, Wytske J. Fokkens, Stephen G. Jenkins, Valerie J. Lund, Mahmood F. Mafee, Robert M. Naclerio, Ruby Pawankar, Jens U. Ponikau, Mark S. SchubertRaymond G. Slavin, Michael G. Stewart, Alkis Togias, Ellen R. Wald, Birgit Winther

Research output: Contribution to journalArticle

179 Citations (Scopus)

Abstract

The Rhinosinusitis Initiative was developed by 5 national societies. The current guidance document is an expansion of the 2004 publication "Rhinosinusitis: Establishing definitions for clinical research and patient care" and provides templates for clinical trials in antimicrobial, anti-inflammatory, and symptom-relieving therapies for the following: (1) acute presumed bacterial rhinosinusitis, (2) chronic rhinosinusitis (CRS) without nasal polyps, (3) CRS with nasal polyps, and (4) classic allergic fungal rhinosinusitis. In addition to the templates for clinical trials and proposed study designs, the Rhinosinusitis Initiative has developed 6 appendices, which address (1) health outcomes, (2) nasal endoscopy and staging of CRS, (3) radiologic imaging, (4) microbiology, (5) laboratory measures, and (6) biostatistical methods.

Original languageEnglish (US)
JournalJournal of Allergy and Clinical Immunology
Volume118
Issue number5 SUPPL.
DOIs
StatePublished - Nov 2006

Fingerprint

Nasal Polyps
Clinical Trials
Microbiology
Nose
Endoscopy
Publications
Patient Care
Anti-Inflammatory Agents
Health
Research
Therapeutics

Keywords

  • Acute bacterial rhinosinusitis
  • allergic fungal rhinosinusitis
  • chronic rhinosinusitis with or without polyps
  • clinical trials

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Cite this

Meltzer, E. O., Hamilos, D. L., Hadley, J. A., Lanza, D. C., Marple, B. F., Nicklas, R. A., ... Winther, B. (2006). Rhinosinusitis: Developing guidance for clinical trials. Journal of Allergy and Clinical Immunology, 118(5 SUPPL.). https://doi.org/10.1016/j.jaci.2006.09.005

Rhinosinusitis : Developing guidance for clinical trials. / Meltzer, Eli O.; Hamilos, Daniel L.; Hadley, James A.; Lanza, Donald C.; Marple, Bradley F.; Nicklas, Richard A.; Adinoff, Allen D.; Bachert, Claus; Borish, Larry; Chinchilli, Vernon M.; Danzig, Melvyn R.; Ferguson, Berrylin J.; Fokkens, Wytske J.; Jenkins, Stephen G.; Lund, Valerie J.; Mafee, Mahmood F.; Naclerio, Robert M.; Pawankar, Ruby; Ponikau, Jens U.; Schubert, Mark S.; Slavin, Raymond G.; Stewart, Michael G.; Togias, Alkis; Wald, Ellen R.; Winther, Birgit.

In: Journal of Allergy and Clinical Immunology, Vol. 118, No. 5 SUPPL., 11.2006.

Research output: Contribution to journalArticle

Meltzer, EO, Hamilos, DL, Hadley, JA, Lanza, DC, Marple, BF, Nicklas, RA, Adinoff, AD, Bachert, C, Borish, L, Chinchilli, VM, Danzig, MR, Ferguson, BJ, Fokkens, WJ, Jenkins, SG, Lund, VJ, Mafee, MF, Naclerio, RM, Pawankar, R, Ponikau, JU, Schubert, MS, Slavin, RG, Stewart, MG, Togias, A, Wald, ER & Winther, B 2006, 'Rhinosinusitis: Developing guidance for clinical trials', Journal of Allergy and Clinical Immunology, vol. 118, no. 5 SUPPL.. https://doi.org/10.1016/j.jaci.2006.09.005
Meltzer, Eli O. ; Hamilos, Daniel L. ; Hadley, James A. ; Lanza, Donald C. ; Marple, Bradley F. ; Nicklas, Richard A. ; Adinoff, Allen D. ; Bachert, Claus ; Borish, Larry ; Chinchilli, Vernon M. ; Danzig, Melvyn R. ; Ferguson, Berrylin J. ; Fokkens, Wytske J. ; Jenkins, Stephen G. ; Lund, Valerie J. ; Mafee, Mahmood F. ; Naclerio, Robert M. ; Pawankar, Ruby ; Ponikau, Jens U. ; Schubert, Mark S. ; Slavin, Raymond G. ; Stewart, Michael G. ; Togias, Alkis ; Wald, Ellen R. ; Winther, Birgit. / Rhinosinusitis : Developing guidance for clinical trials. In: Journal of Allergy and Clinical Immunology. 2006 ; Vol. 118, No. 5 SUPPL.
@article{a8ce3d8655e6401cbb355ee7d5f472c0,
title = "Rhinosinusitis: Developing guidance for clinical trials",
abstract = "The Rhinosinusitis Initiative was developed by 5 national societies. The current guidance document is an expansion of the 2004 publication {"}Rhinosinusitis: Establishing definitions for clinical research and patient care{"} and provides templates for clinical trials in antimicrobial, anti-inflammatory, and symptom-relieving therapies for the following: (1) acute presumed bacterial rhinosinusitis, (2) chronic rhinosinusitis (CRS) without nasal polyps, (3) CRS with nasal polyps, and (4) classic allergic fungal rhinosinusitis. In addition to the templates for clinical trials and proposed study designs, the Rhinosinusitis Initiative has developed 6 appendices, which address (1) health outcomes, (2) nasal endoscopy and staging of CRS, (3) radiologic imaging, (4) microbiology, (5) laboratory measures, and (6) biostatistical methods.",
keywords = "Acute bacterial rhinosinusitis, allergic fungal rhinosinusitis, chronic rhinosinusitis with or without polyps, clinical trials",
author = "Meltzer, {Eli O.} and Hamilos, {Daniel L.} and Hadley, {James A.} and Lanza, {Donald C.} and Marple, {Bradley F.} and Nicklas, {Richard A.} and Adinoff, {Allen D.} and Claus Bachert and Larry Borish and Chinchilli, {Vernon M.} and Danzig, {Melvyn R.} and Ferguson, {Berrylin J.} and Fokkens, {Wytske J.} and Jenkins, {Stephen G.} and Lund, {Valerie J.} and Mafee, {Mahmood F.} and Naclerio, {Robert M.} and Ruby Pawankar and Ponikau, {Jens U.} and Schubert, {Mark S.} and Slavin, {Raymond G.} and Stewart, {Michael G.} and Alkis Togias and Wald, {Ellen R.} and Birgit Winther",
year = "2006",
month = "11",
doi = "10.1016/j.jaci.2006.09.005",
language = "English (US)",
volume = "118",
journal = "Journal of Allergy and Clinical Immunology",
issn = "0091-6749",
publisher = "Mosby Inc.",
number = "5 SUPPL.",

}

TY - JOUR

T1 - Rhinosinusitis

T2 - Developing guidance for clinical trials

AU - Meltzer, Eli O.

AU - Hamilos, Daniel L.

AU - Hadley, James A.

AU - Lanza, Donald C.

AU - Marple, Bradley F.

AU - Nicklas, Richard A.

AU - Adinoff, Allen D.

AU - Bachert, Claus

AU - Borish, Larry

AU - Chinchilli, Vernon M.

AU - Danzig, Melvyn R.

AU - Ferguson, Berrylin J.

AU - Fokkens, Wytske J.

AU - Jenkins, Stephen G.

AU - Lund, Valerie J.

AU - Mafee, Mahmood F.

AU - Naclerio, Robert M.

AU - Pawankar, Ruby

AU - Ponikau, Jens U.

AU - Schubert, Mark S.

AU - Slavin, Raymond G.

AU - Stewart, Michael G.

AU - Togias, Alkis

AU - Wald, Ellen R.

AU - Winther, Birgit

PY - 2006/11

Y1 - 2006/11

N2 - The Rhinosinusitis Initiative was developed by 5 national societies. The current guidance document is an expansion of the 2004 publication "Rhinosinusitis: Establishing definitions for clinical research and patient care" and provides templates for clinical trials in antimicrobial, anti-inflammatory, and symptom-relieving therapies for the following: (1) acute presumed bacterial rhinosinusitis, (2) chronic rhinosinusitis (CRS) without nasal polyps, (3) CRS with nasal polyps, and (4) classic allergic fungal rhinosinusitis. In addition to the templates for clinical trials and proposed study designs, the Rhinosinusitis Initiative has developed 6 appendices, which address (1) health outcomes, (2) nasal endoscopy and staging of CRS, (3) radiologic imaging, (4) microbiology, (5) laboratory measures, and (6) biostatistical methods.

AB - The Rhinosinusitis Initiative was developed by 5 national societies. The current guidance document is an expansion of the 2004 publication "Rhinosinusitis: Establishing definitions for clinical research and patient care" and provides templates for clinical trials in antimicrobial, anti-inflammatory, and symptom-relieving therapies for the following: (1) acute presumed bacterial rhinosinusitis, (2) chronic rhinosinusitis (CRS) without nasal polyps, (3) CRS with nasal polyps, and (4) classic allergic fungal rhinosinusitis. In addition to the templates for clinical trials and proposed study designs, the Rhinosinusitis Initiative has developed 6 appendices, which address (1) health outcomes, (2) nasal endoscopy and staging of CRS, (3) radiologic imaging, (4) microbiology, (5) laboratory measures, and (6) biostatistical methods.

KW - Acute bacterial rhinosinusitis

KW - allergic fungal rhinosinusitis

KW - chronic rhinosinusitis with or without polyps

KW - clinical trials

UR - http://www.scopus.com/inward/record.url?scp=33750432176&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33750432176&partnerID=8YFLogxK

U2 - 10.1016/j.jaci.2006.09.005

DO - 10.1016/j.jaci.2006.09.005

M3 - Article

C2 - 17084217

AN - SCOPUS:33750432176

VL - 118

JO - Journal of Allergy and Clinical Immunology

JF - Journal of Allergy and Clinical Immunology

SN - 0091-6749

IS - 5 SUPPL.

ER -